Juvic is Yonsei University's first faculty-led startup, collaborating closely on research and development with the university's Department of Biotechnology lab.

Traditional vaccines face issues related to cold chain distribution, the need for professional administration, and medical waste generation; Juvic aims to address these challenges using microneedle technology.

Juvic holds drug-loading technology that allows the formation of a separate drug core, not a simple mixture, ensuring stability under optimal conditions for each drug and enabling the loading of multiple drugs in a single patch.

With proprietary centrifugal molding technology, Juvic can manufacture microneedles without thermal or UV stimulation, preserving drug activity.

Juvic's centrifugal molding technology enables the production of microneedles in a candlelit shape rather than the typical conical shape, maximizing drug delivery efficiency.

Juvic’s skin application technology ensures precise insertion and delivery.